Abstract
Exploring the pathophysiology underlying diabetes mellitus requires characterizing the cellular constituents of pancreatic islets, primarily insulin-producing β-cells. Such efforts have been limited by inadequate techniques for purifying islet cellular subsets for further biochemical and gene-expression studies. Using intracytoplasmic staining and fluorescence-activated cell-sorting (FACS) followed by quantitative nuclease protection assay (qNPA™) technology, we examined 30 relevant genes expressed by islet subpopulations. Purified islet cell subsets expressed all four tested “housekeeping” genes with a surprising variability, dependent on both cell lineage and developmental stage, suggesting caution when interpreting housekeeping gene-normalized mRNA quantifications. Our new approach confirmed expected islet cell lineage-specific gene expression patterns at the transcriptional level, but also detected new phenotypes, including mRNA-profiles (supported by immunohistology) demonstrating that during pregnancy, some β-cells express Mafb, previously found only in immature β-cells during embryonic development. Overall, qNPA™ gene expression analysis using intracellular-stained then FACS-sorted cells has broad applications beyond islet cell biology.
Keywords: islet cell subsets, flow cytometry, gene expression, nuclease protection, immunohistochemistry
Tissues are complex cellular aggregates, whose functional properties are dictated by the unique set of genes they express. Islets of Langerhans, for instance, the glucose-controlling mini-organs dispersed throughout the pancreas, harbor phenotypically different cells of distinct endocrine, neuronal, mesenchymal, and hematopoetic lineages1. Pancreatic islets regulate carbohydrate metabolism by secreting insulin (from β-cells) and glucagon (from α-cells), while other islet cell subsets provide vascularization, innervation, and structural support. Islets can be isolated for transplantation or to examine their functional properties ex vivo or in vitro2, but dissecting islets into functional cell subsets for analytical purposes has been difficult3. Since surrogate endocrine cell surface markers have not been identified, hormone-secreting islet cells are defined and characterized by their cytoplasmic hormone content. Using flow cytometry (FCM), we have recently dissected islet cell suspensions into endocrine lineage subsets by employing a multiparameter staining approach involving intracytoplasmic hormone-staining using paraformaldehyde (PFA)-fixed, membrane-permeabilized islet cells4,5.
To date quantitative information of individual islet cell subsets has been vague, presumed from whole islet cell preparations, or estimated from protein expression patterns or fluorescence in situ hybridizations6. Others have obtained intact full-length RNA required for conventional gene expression analysis by Northern blot analysis or RT-PCR from FACS-purified, genetically-marked, viable islet cells7,8. Whereas paraformaldehyde (PFA)-fixation and membrane-permeabilization, necessary for intracellular staining, prevents conventional full-length RNA isolation due to chemical cross-linking of proteins and nucleic acids9, such paraformaldehyde-induced cross-linking does not interfere with short cDNA-probe RNA hybridizations used by nuclease protection analysis, an established technique for quantifying specific cellular mRNA transcripts10,11. We therefore reasoned that the technique may be applicable to fixed cells, and sought to combine our ability to purify the multiple islet cell subsets by intracytoplasmic flow cytometry4 with gene expression analysis using a nuclease protection technique, optimized to meet high-throughput formats with minimal cell input12. Fig. 1a illustrates the qNPA™ detection strategy. Multiple RNA sequence-protecting cDNA probes are captured to defined locations on a microplate support, then quantified by measuring chemiluminescence. Customized arrays using complementary cDNA-probes targeting gene-specific 50-mer RNA-motifs were designed for mouse islet cell studies (Supplementary Tables 1 and 2). Fig. 1b exhibits a charge-coupled device (CCD) camera-captured luminescence profile of purified, non-dissociated islets (top), and the multiwell-plate localization map of individual genes (bottom).
Fig 1.
Islet cell gene transcription by qNPA™ is quantitative and not influenced by cell fixation. (a) Illustration of qNPA™ technology. An array of selected 50-mer cDNA probes were hybridized with whole islet cell lysates, followed consecutively by single-strand nucleic acid digestion, denaturizing, RNA digestion, and hybridization to programming linkers specifically positioned by pre-printed anchors on the qNPD array plate. Quantitative detection was achieved by hybridizing to gene-sequence specific detection linkers, and visualized by horseradish-peroxidase generated luminescence. (b) CCD camera-captured image (top) and schematic gene locations (bottom) of approx. 100 isolated adult islets, visualizing sparse genes at the expense of overloading abundant genes. (c) mRNA content is not decreased by PFA fixation, prolonged membrane permeabilization, and high-speed FACS-sorting. Aliquots of dissociated adult mouse MIP-eGFP transgenic islet cells, which characteristically display two GFP-intensities by flow cytometry (inset), were either left untreated or were PFA-fixed, permeabilized, and washed six times. Then cells were sorted into GFP(+) and GFP(−) cells and analysed by qNPA™. Results of all consistently expressing Array#1 mRNA targets (Supplementary Table 1) from FACS-purified GFP(+) (green symbols) and GFP(−) (black symbols) were normalized to LU/1,000 cells, plotted together and tested for best fit (r2=0.97). The line indicates 45-deg angle. One of two comparable experiments are shown. (d), Simultaneous multi-gene qNPA™-luminiscence generated by graded dilution of whole islet cell lysates. Triplicate determinations (mean +/− SE) of 2-fold dilutions are plotted. Note that qNPA™ is quantitative between its luminescence sensitivity threshold close to 10, and a light density of at least 10,000 cpm (LU). One of multiple similar dilution experiments is shown.
Using mouse islet cell suspensions (Supplementary Fig. 1a), and a mouse insulinoma cell line (Min6, Supplementary Fig. 1b) we tested the effect of paraformaldehyde (PFA) fixation on mRNA-detection. Split-sample aliquots of fresh and PFA-fixed/permeabilized aliquots were analyzed in parallel. qNPA™ -detected gene-specific mRNA levels were indistinguishable between fresh and PFA-fixed/permeabilized samples, with no discernible impact on transcript abundance. Next we examined if mRNA transcripts are lost if such PFA-fixed cells are saponin-permeabilized and subjected to staining procedures in the presence of detergents, and then high-speed FACS sorting. Fig. 1c demonstrates that little or no loss of cellular mRNA occurred, while a tight regression (r2=0.97) indicates that all gene-specific transcripts were affected similarly. Similar results were also obtained with Min6 insulinoma cells (Supplementary Fig. 2). Finally, graded dilutions of sample input confirmed that qNPA™ is quantitative over a gene-transcript range of approximately 3 orders of magnitude (Fig. 1d). Excellent quantitative dilution curves were also obtained from tissues containing lower islet cell gene transcripts (i.e by manually depleting the visible islets from viable pancreatic digests), Min6 cells, or purified whole islet RNA (Supplementary Fig. 3a–c).
Having established that qNPA™ is compatible with PFA-fixation and saponin-permeabilization and that it is quantitative over a broad dynamic range, we tested the technique using FACS-purified major endocrine islet cell subsets from healthy C57BL/6 mice. We applied combination gates throughout to define single-cell suspensions of the three major endocrine cell subsets β-, α-, and δ-cells, respectively secreting insulin, glucagon, and somatostatin. The gates consisted sequentially of forward (FSC)/sideward scatter (SSC), doublet exclusion13, and the separation of all three populations from each other and from non-specifically stained debris introduced by the ribonuclease (RNase)-inhibitor vanadyl ribonucleoside complexes (VRC). VRC was present throughout all staining steps to prevent RNA degradation. Optically, VRC caused the appearance of primarily very small, multi-fluorescent ”particles” (Fig. 2a, grey-colored population in dot plots), which when purified by FACS and analyzed by qNPA™ did not contain gene-specific mRNA, resembling apoptotic cells containing only degraded RNA (data not shown). Fig. 2a illustrates the purity of FACS-prepared endocrine subsets, as demonstrated by re-analysis of small aliquots of the sorted cells (middle panel). Supplementary Table 3 displays the endocrine cell frequencies of islet cell suspensions before and after FACS. Purified cells were then submitted to gene expression analysis by qNPA™. CCD-camera images exhibit the expected and quite distinct gene-expression profile among the cell populations (Fig. 2a, compare to unseparated islet cells in Fig. 1b). These results were then quantified, normalized to chemiluminescence per 1,000 cells, and displayed in Fig 2a, right panel. As expected, all endocrine subsets expressed those genes whose protein product was used for sorting, and the rigorous purification regimen resulted in negligible cross-contaminating gene expression. More importantly, we note that the three major endocrine subsets exhibit different steady-state hormone-encoding mRNA transcript levels; that is, normal adult mouse α- and β-cells produced on average substantially more hormone transcripts than δ-cells (Fig. 2a, right panel, top 2 vs. 3rd chart). Interestingly, while pancreatic polypeptide (Ppy) transcripts were found as expected in the unstained islet cell population (Fig. 2a, lowest chart), we also observed that δ-cells appeared to express Ppy mRNA. This suggests that some δ-cells may co-express Ppy and somatostatin (Sst), a possibility that to our knowledge has not been adequately addressed in the literature. An alternative explanation is that Sst(+) Ppy(+) doublets form unusually strong heterologous interactions that resist dissociation, and are small enough to escape our forward light scatter-based doublet exclusion strategy.
Fig. 2.
Dissection, purification and gene-expression analysis of islet cell subsets by FACS-sorting and qNPA™. (a) Whole islets were dissociated, fixed and intracytoplasmically stained for insulin, glucagon, and somatostatin. Single islet cells were then FACS-purified to near homogeneity for the three major endocrine islet cell subsets, simultaneously 4-way sorted, with all unstained cells (3-negative) also collected (histogram panel). Purified populations were then subjected to qNPA™. Individual captured CCD-camera images had cell input as follows: Ins(+) 6,000; Gcg(+) 6,000; Sst(+) 2,500; and 3-neg 10,000 (middle panel). Gene expression rate (luminescence normalized to 1,000 cells) was calculated from duplicate assays for each of at least n=3 dilutions. Mean+/−SEM of normalized dilutions are shown. (b)“Housekeeping” gene expression varies among individual adult islet cell subsets. Four commonly used ubiquitously-expressed genes were tested. Ppia and Actb (Array 1), Hrpt1 and Rsp29 (Array 2). The four genes were expressed in all islet cell subsets, although at very different, highly variable levels. n=4 (array 1), and n=3 (array 2) independent healthy, adult islet cell preparations and FACS-purified subsets were tested, respectively. Results shown are the cell input-normalized mean +/− SE. Statistical significance levels are indicated (*) p<0.05, and (**) p<0.02.
Our qNPA™ panels included quantification of four ubiquitously-expressed so-called “housekeeping” genes (Ppia, Actb, Hprt1, and Rsp29, Supplementary Tables 1 and 2), used to normalize and compare gene-transcription between tissues14,15. We were surprised to find that none of them were equivalently expressed among the three major endocrine islet cell subsets or non-endocrine islet cells (Fig. 2b), consistent with general concerns about using “housekeeping” genes to normalize gene-expression between different tissues16. Normalization to any one or all four tested housekeeping genes would have distorted comparisons between phenotypically (Fig. 2b) or developmentally distinct islet cell populations (Supplementary Table 4), or from diseased or genetically-mutated mice. We elected therefore to normalize gene-expression to the precise number of cells dispensed and recorded by the cell sorter’s software. Table 1 shows the gene-expression pattern characterizing the four sorted adult islet cell subsets: β-, α-, δ-cells, plus all remaining cells, termed non-endocrine cells (3-neg). The results confirm several previous proposals on the distribution of islet subset-enriched gene products, based largely on multicolor immunofluorescence, gene mutational analysis, or transformed cell lines17. For instance, our data supports studies demonstrating β-cell expression of both prohormone convertases 1/3 (Pcsk1) and 2 (Pcsk2), whereas α-cells express only Pcsk218,19. For most genes tested, clear lineage segregation was apparent in healthy adult islets (Table 1) supporting the current consensus of islet biology and function, as discussed in more detail in recent reviews20,21. Specifically, β-cells expressed Nkx2-2, Nkx6-1, Mafa, Pdx-1, and Glp1r, whereas Mafb mRNA expression was detected only in α-cells22, and interestingly also in the non-endocrine compartment. In agreement with published reports23,24 Neurod1 and the zinc transporter Slc30a8 were detected in both α- and β-cells. On the other hand, we found Pax6 expression in adult β-cells, somewhat less in δ-cells, and none in adult α-cells. The latter observations differs from the prevailing view of endocrine cell lineage patterns where Pax6 is thought to be a panendocrine marker25.
Table 1.
qNPA gene expression profiles of FACS-purified islet cell subsets from adult mice and during development.
Genesa | β-cells | α-cells | δ-cells | 3-neg | ||||||
---|---|---|---|---|---|---|---|---|---|---|
adult | juvenile | embryo | pregnant | adult | juvenile | embryo | pregnant | adult | adult | |
endocrine | ||||||||||
Ins2 | 6734 ± 880 | 6469 ± 1308 | 748 ± 244 | 8259 ± 517 | 5 ± 1 | 24 ± 7 | 4 ± 2 | 13 ± 5 | 142 ± 72 | 357 ± 161 |
Gcg | 9± 2 | 31 ± 11 | 43 ± 13 | 14 ± 2 | 6079 ± 667 | 17550 ± 1191 | 5314 ± 914 | 15730 ± 1064 | 20 ± 14 | 8 ± 1 |
Sst | nd | nd | nd | 6 ± 1 | 4 ± 1 | 14 ± 5 | nd | 19 ± 7 | 1067 ± 360 | nd |
Ppy | 42 ± 9 | 115 ± 59 | 7 ± 3 | 40 ± 6 | 221 ± 22 | 452 ± 73 | 28 ± 9 | 481 ± 105 | 460 ± 145 | 1545 ± 461 |
Iapp | 2581 ± 704 | 2479 ± 148 | 492 ± 208 | 2782 ± 444 | 16 ± 3 | 36 ± 4 | 74 ± 16 | 20 ± 1 | 258 ± 106 | 50 ± 18 |
exocrine | ||||||||||
Amy2 | 18 ± 7 | 113 ± 55 | 171 ± 36 | 48 ± 32 | 39 ± 22 | 53 ± 24 | 57 ± 29 | 82 ± 41 | nd | 1485 ± 437 |
differentiation | ||||||||||
Nkx2-2 | 17 ± 4 | 14 ± 1 | 16 ± 6 | 23 ± 2 | nd | 10 ± 0 | 13 ± 4 | 14 ± 3 | nd | nd |
Nkx6-1 | 85 ± 19 | 67 ± 1 | 69 ± 27 | 95 ± 16 | nd | nd | 4 ± 4 | 5 ± 2 | nd | nd |
Pax6 | 21 ± 7 | 29 ± 6 | 9 ± 3 | 33 ± 6 | nd | 8 ± 3 | 20 ± 6 | 8 ± 1 | 5 ± 3 | nd |
Mafa | 15 ± 3 | 16 ± 7 | 4 ± 2 | 29 ± 7 | nd | nd | nd | nd | nd | nd |
Mafb | nd | 3 ± 1 | 26 ± 7 | 9 ± 2 | 10 ± 2 | 42 ± 9 | 33 ± 6 | 24 ± 4 | nd | 9 ± 2 |
Neurod1 | 28 ± 7 | 33 ± 3 | 22 ± 9 | 35 ± 7 | 10 ± 5 | 19 ± 2 | 10 ± 8 | 15 ± 4 | 6 ± 4 | nd |
Pdx-1 | 18 ± 6 | 15 ± 2 | 16 ± 6 | 29 ± 2 | nd | nd | nd | nd | nd | nd |
other | ||||||||||
Pcsk1 | 96 ± 31 | 92 ± 8 | 98 ± 44 | 121 ± 18 | nd | nd | nd | nd | nd | nd |
Pcsk2 | 243 ± 62 | 225 ± 30 | 128 ± 50 | 264 ± 39 | 252 ± 68 | 323 ± 40 | 148 ± 57 | 315 ± 55 | 128 ± 34 | 18 ± 1 |
Ccnd2 | 25 ± 7 | 35 ± 9 | 8 ± 1 | 42 ± 6 | 9 ± 1 | 36 ± 8 | 7 ± 1 | 24 ± 7 | nd | 4 ± 1 |
Slc30a8 | 172 ± 27 | 199 ± 29 | 103 ± 43 | 171 ± 32 | 81 ± 27 | 123 ± 20 | 47 ± 18 | 106 ± 28 | nd | 5 ± 0 |
Glp1r | 147 ± 61 | 77 ± 3 | 23 ± 11 | 166 ± 41 | nd | nd | nd | nd | nd | nd |
gene expression represents the average gene-specific qNPA™ chemiluminescence (mean ± SEM) of n=3–5 independent experiments using FACS-purified islet cell or embryonic endocrine subsets from healthy adult mice (bold), or during developmental stages.
, upregulated genes (>2-fold over adult mRNA levels, or not detectable in adult cells ).
, downregulated genes (>2-fold below adult mRNA levels). nd, not detected (means < 3).
“” numbers, the experimental design and the FACS gating strategy for insulin, glucagon, and somatostatin increased the sorted islet subset purity, but prevented addressing the existence of dual hormones expression by a small minority of β-, α-, or δ cells (see Fig. 2a and Methods). Greyed numbers therefore indicate this limitation
Satisfied that the technique accurately measures the expected transcript levels in isolated cell subsets, we further examined gene expression in β- and α-cells at times of physiologically-elevated generative or functional activity, such as embryonic development, adolescence, and metabolic adjustments during pregnancy. These studies revealed a profoundly altered picture (Table 1, cursive font) with several notable observations. For example, relative to adult β-cells, embryonic ins(+) β-cells express approximately 10 fold less insulin mRNA, similarly reduced islet amyloid polypeptide (Iapp) and diminished Pax6, Mafa, Ccnd2, and Glp1r mRNA (Table 1, light grey cells), consistent with their functional immaturity in E15.5–E18.5 embryonic mice. Unlike β-cell insulin transcripts, α-cell glucagon mRNA at the same gestational age did not differ much from adult α-cells. Also, the expression of Gcg and Mafb was substantially higher in α-cells during phases of increased metabolic demand (pregnancy, adolescence) relative to normal adult mouse α-cells (Table 1, dark grey cells). Such profoundly enhanced function was not observed in β-cells of the same mice. Finally, the absolute lineage segregation observed with regard to several key transcription factors in normal adult islet cells (Nkx2-2, Nkx6-1, Pax6), was lost as reflected by the detectable to substantial transcript levels found in embryonic hormone-secreting cells, or during pregnancy (Table 1, dark grey cells). These data suggest that α-cells can turn on some (but not all) typical β-cell lineage genes under certain conditions or at different developmental stages. Our findings are consistent with a greater than expected plasticity in islet cell gene expression patterns during physiological challenges in adult mice.
We wish to draw particular attention to Mafa and Mafb, members of the basic leucine zipper v-maf transcription factor family, which are involved in the development and/or function of various organ systems26. In the pancreas, Mafa facilitates insulin gene expression, and islet β-cell function27,28, but is not involved in embryonic β-cell differentiation prior to the second transition phase28. Unlike Mafa, Mafb-expression has been associated with islet α- and β-lineage decisions during embryonic development22,29, and is important for glucagon gene expression in α-cells29. Specifically, we and others have shown that embryonic, immature β-cells temporarily express Mafb prior to the second transition22,29, suggesting it plays a role in embryonic β-cell neogenesis, differentiation, and/or maturation. While we could not detect Mafb mRNA in normal adult islet β-cells, qNPA™ revealed Mafb mRNA in purified β-cells isolated from pregnant mice, and to a somewhat lesser extent in adolescent mice (Fig. 3a). We next histologically examined pancreas tissue sections to test whether MafB protein was expressed and to assess cellular heterogeneity of β-cell Mafb expression. As shown in Fig. 3b, pancreata from pregnant mice revealed a small but distinct population of Ins(+)Mafb(+) double stained cells amidst the majority of Ins(+)Mafb(−) β-cells. Since others have demonstrated that pregnant mouse β-cells undergo cell replication during the gestational period30, we tested if β-cell Mafb is preferentially expressed in those cells caught in cell cycle progression. We administered BrdU for 6h to pregnant mice on gestational day 15.5, then examined the pancreata by immunohistology (Fig. 3c). We found the expected small subset of pancreatic Ins(+) β-cells with nuclear BrdU indicating recent cell division, but we found no Ins(+)BrdU(+) β-cells that co-stained for Mafb protein. These results are consistent with the possibility that during pregnancy the increased metabolic demand is met by both enhanced β-cell proliferation and facilitated β-cell differentiation.
Fig. 3.
Facultative MafB expression in adult mouse β-cells. A, MafA (black), and MafB (grey) gene expression profile of FACS-sorted Ins(+) and Gcg(+) cells. As expected, MafB but not MafA was detectable in Gcg(+) α-cells while MafA was present in β-cells. Whereas MafB was absent in normal, adult β-cells (n=3 independent experiments using 8–12 week-old mouse islets), MafB transcripts were detected in juvenile (3–4 weeks, n=4), embryonic (E15.5–18.5, n=4), and pregnant pancreata (same gestational age as embryonic pancreata, n=4). B, A small subset of Ins(+) islet cells from pregnant mouse pancreas express MafB. Naïve (upper), and pregnant mouse pancreas (lower panel) were examined. Co-staining for insulin and MafB (left panel), and glucagon and MafB (right panel) are shown. Arrows denote MafB(+) β-cells (yellow) and MafB(+) α-cells (white), respectively. C, MafB is not expressed in BrdU-labeled (proliferating) β-cells at day 15.5 of pregnancy. Naïve and pregnant mice were given BrdU (3 i.p. injections, 2h apart), and their pancreata were then assessed for BrdU-incorporation and MafB expression using standard immunohistochemical techniques. Naïve mouse β-cells displayed no BrdU-uptake and no MafB staining. Pregnant mice displayed both BrdU(+) (blue nuclei, white arrows) and MafB(+) cells (green nuclei, yellow arrows) that also stained for insulin. However, we detected no cells staining for both BrdU and MafB.
We have recently argued that multicolor flow cytometry represents a powerful analytical tool to study islet cell biology4,5, but suffered, like immunofluorescence microscopy, from the inability to study islet cell-subset gene-expression profiles. Combining FACS-sorting with qNPA™ analysis overcomes this limitation and is ideally suited to profile endocrine or non-endocrine islet cell populations in health and disease. We demonstrate for the first time that multiple different islet cell subsets can be purified simultaneously, allowing each subsets’ transcriptome to be analyzed. Moreover, the exceedingly efficient and sensitive qNPA™ technology can be applied using as few as 103–104 cells per array of currently 15 genes, an easily achievable cell-yield even for rare cells using standard high-speed cell sorters. Further, we envision many other applications, not limited to islet cell biology, for the technique as it can be applied to cells identified by cytoplasmic or nuclear antigens previously very difficult to characterize since sorting such cells also requires fixation. qNPA™ of FACS-sorted cells will permit much more specific insight into the regulation of cellular function in tissues, including human specimens, whose viable cell subsets can not be genetically marked nor purified using cell surface markers.
METHODS
Animals
C57BL/6 mice were obtained from the central NCI repository, Frederick, MD and further bred in house. Adult (8–14 weeks), juvenile (20–26 days), and pregnant mice (8–12 weeks, E15.5–E18.5) were used as source of purified pancreatic islets. Embryonic mouse pancreatic buds were collected and pooled for both immunohistochemical and flow-cytometric-based techniques. Mouse insulin promoter (MIP) eGFP mice were used as source of islets in some experiments. Mice were housed at the Division of Veterinary Resources, NIH, in accordance with the guidelines set forth by the Committee on the Care and Use of Laboratory Animals on a protocol approved by the Animal Care and Use Committee of the NIDDK.
Islet isolation, intracellular staining, and flow cytometry
Pancreatic islets from adult and juvenile mice were isolated using standard techniques, involving bile duct cannulation, pancreas inflation using 3–4 ml of ice-cold collagenase type V (1 mg/ml, Sigma-Aldrich, in HBSS), and digestion for 14 minutes at 37° C. Then pancreas digests were further broken apart by aspirating through a 14G needle and filtered through a metal strainer (0.8 mm). Viable pancreatic tissue including the vast majority of islets were obtained following buoyant density gradient centrifugation (14–15% Optiprep, Accurate Chemicals, Westbury, NY), and islets were further purified by handpicking. Isolated islets (and islet-depleted cells) were dissociated into a single cell suspension by gentle pipeting after washing in 2 mM EDTA/PBS, and incubating for 10 minutes at ambient temperature in Ca2+-free phosphate buffered saline (PBS) supplemented with 0.025% trypsin. Dissociated islet cells were washed in PBS and immediately fixed and permeabilized (4% paraformaldehyde [PFA], 0.1% saponin/PBS, 30 min). Pancreatic islets from pregnant C57BL/6 mice (gestational day 15.5–18.5) were isolated as above, stained and sorted individually and not pooled with other pregnancies. Pancreata from embryonic mice (9–15 embryos from 1–2 litters) were pooled, digested (20 min, 1 mg/ml collagenase type V, 37° C), gently resuspended and filtered (35 μm cell-strainer tubes, BD Falcon). Single cell suspensions were then fixed, permeabilized and stained. After fixation, all buffers were verified RNase-free, including BSA (0.2% in wash buffer, and 1% during staining, Lifeblood Medical, Freehold, NJ, or Gemini Bio-Products, West-Sacramento, CA). Essential serum or protein containing reagents (e.g. antisera, purified polyclonal secondary antibodies), were used at a titered low concentration in the presence of 15 mM vanadyl ribonucleoside complexes (VRC, Sigma-Aldrich). Intracytoplasmic staining was performed for 30 minutes with antibodies to insulin (guinea pig, DAKO), and two mouse IgG1 monoclonal antibodies specific for glucagon (K79bB10, Sigma-Aldrich) and somatostatin (SOM018, antibody core facility, Beta Cell Biology Consortium, Denmark). Simultaneous staining using both mouse IgG1 antibodies required Invitrogen’s Zenon (pre)labeling technology (Pacific Blue, AlexaFluor488). Highly cross-absorbed, second-step anti-guinea pig-Cy5 polyclonal antibodies were from Jackson ImmunoResearch. After the final wash in 0.2%BSA/saponin, cells were post-fixed in 2% PFA and immediately sorted on an ARIA high-speed cell sorter (3-laser, 11-color, up to 70 psi sample pressure, DIVA 6.0 software (BD Biosciences), using RNase-free (i.e. commercial grade) PBS for pre-sort flushing and sheath fluid.
Electronic gating was set to exclude non-viable cells (before PFA-fixation) on the basis of forward versus side scatter. The doublet exclusion gating strategy relied on pressurized sheath flow, or hydrodynamic focusing, which favors longitudinal alignment of occasional, non-dissociated islet cell aggregates in the narrow core sample stream. These aggregates are then detected and excluded by linear FSC-width versus –height based electronic gating algorithms13. This way islet cell couplets are diminished by approximately 20-fold4,5. The next gating level electronically separated insulin-staining from non-stained cells (Fig. 2a, left). Both populations were subsequently displayed for Gcg-staining (y-axis) and Sst-staining (x-axis), and then gated for Ins(+) cells (Fig. 2a, top FACS-plot) or Gcg(+), Sst(+) staining cells, or subpopulations negative for all three hormones (Fig. 2a, bottom FACS-plot). This gating strategy ensured the best distinction between β-, α-, and δ-cells, thereby increasing each endocrine subset’s specificity for subsequent gene expression analysis. However, such gating effectively eliminated any rare cells that might express two-hormones within the same cell. We emphasize therefore that the gating strategy was not designed to test if more than one major hormone (Ins, Gcg, or Sst) could be expressed in the same cell. Reflecting that fact, the relevant cells in Table 1 display the data we obtained but within hatched fields.
Quantitative nuclease protection array
Immediately after FACS sorting, purified islet cell subsets were pelleted and resuspended in Lysis Buffer (High Throughput Genomics [HTG], Tuczon, AZ), heated to 95° C for 10 minutes, chilled and stored frozen at −80° C until processing. Cell lysates were processed applying the manufacturer’s instructions and reagents throughout (HTG). Briefly, islet cell lysates were hybridized with cDNA riboprobes for 6 hours at 60° C, followed by S1-Nuclease digestion for 30 minutes at 50° C effectively eliminating single strand nucleic acids. Enzymatic reaction was terminated by adding 10 μl S1 Stop Solution, and consecutive incubation at 95° C and 22° C for 10 minutes each. After adding 10 μl Neutralizing Solution, samples were transferred to our custom designed ArrayPlate (96-16), manufactured to capture preselected islet cell transcripts. cDNAs contained in the sample were allowed to hybridize at 50° C overnight to the ArrayPlate-immobilized Programming Linkers. Detection linkers were added for the last 1 h, followed in turn by multiple thorough washings, and the addition of Detection Enzyme (30 minutes at 37° C). After washing, we added Luminescence Substrate (50 μl/well), and imaged the plate using the Omix Imager. Captured CCD-camera images were analyzed using SI Image SGL software. Specific luminescence intensity for each gene location on the ArrayPlate was determined by subtracting backgound signals (Arabidopsis thaliana ANT, Accession # U41339) included with each array. Comparing gene expression between islet cell subsets and endocrine cell developmental stages, chemiluminescence (LU) captured for 1 min (LU/min) was arithmetically normalized to LU/1,000 cells, extrapolating LU/1,000 cells’ rates into single digits. Gene expression was considered present when biological replicates had an average of >=3 LU/1,000 cells (arbitrary threshold) and at least 66% of biological replicates reached that threshold.
Immunofluorescence microscopy
The primary antibodies used were guinea pig anti-insulin (1:2000 dilution; Linco Research, Inc. 4010-01), guinea pig anti-glucagon (1:2000; Linco Research, Inc. 4030-01F), rabbit anti-Mafb (1:10000; Bethyl laboratories, IHC-00351), and rat anti-BrdU (1:200; Accurate Chemical, OBT0030). Antigen retrieval was performed in Tris-EGTA, pH9.0 buffer for Mafb staining. The secondary Cy3-, Cy5-, or Cy2-conjugated donkey anti-rabbit, anti-guinea pig, and anti-rat IgGs were purchased from Jackson ImmunoResearch Laboratories, Inc. Nuclear counterstaining was performed using YoPro1 (Invitrogen). Immunofluorescence was performed using confocal microscopy (LSM510, Carl Zeiss, Inc).
Statistical analysis
An independent (unpaired) Student’s T Test (two-tailed) was chosen to test the significance of differences among means of small ‘n’ sample sets. Simple linear regression analysis (Pearson) was performed, and the regression coefficient (r2) calculated where indicated.
Supplementary Material
Acknowledgments
The authors like to thank Alice Franks for mouse colony management, and Drs Wank, Gavrilova, and Weinstein for critically reading the manuscript and helpful suggestions. This research was supported, in part by the Intramural Research Program of the NIH, NIDDK, and NIH DK042502, JDRF 1-2008-595 to R.S.
Non-standard abbreviations
- FACS
fluorescence-activated cell-sorting
- BrdU
5-bromo-2-deoxyuridine
- PFA
paraformaldehyde
- CCD
charge-coupled device
- VRC
vanadyl ribonucleoside complexes
- qNPA™
quantitative nuclease protection array
Footnotes
AUTHORS CONTRIBUTIONS: K.P., D.M.H., designed experiments; S.P., M.S., G.W., Y.H., K.P. adapted and refined procedures, and generated data; B.S., R.M., R.S. provided expertise on specific technology and guidance; K.P. and D.M.H wrote and edited manuscript, respectively.
References
- 1.Brissova M, Fowler MJ, Nicholson WE, Chu A, Hirshberg B, Harlan DM, Powers AC. Assessment of human pancreatic islet architecture and composition by laser scanning confocal microscopy. J Histochem Cytochem. 2005;53:1087–1097. doi: 10.1369/jhc.5C6684.2005. [DOI] [PubMed] [Google Scholar]
- 2.Nadal A, Quesada I, Soria B. Homologous and heterologous asynchronicity between identified alpha-, beta- and delta-cells within intact islets of Langerhans in the mouse. J Physiol. 1999;517 (Pt 1):85–93. doi: 10.1111/j.1469-7793.1999.0085z.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 3.Ahn YB, Xu G, Marselli L, Toschi E, Sharma A, Bonner-Weir S, Sgroi DC, Weir GC. Changes in gene expression in beta cells after islet isolation and transplantation using laser-capture microdissection. Diabetologia. 2007;50:334–342. doi: 10.1007/s00125-006-0536-5. [DOI] [PubMed] [Google Scholar]
- 4.Pechhold K, Zhu X, Harrison VS, Lee J, Chakrabarty S, Koczwara K, Gavrilova O, Harlan DM. Dynamic Changes in Pancreatic Endocrine Cell Abundance, Distribution, and Function in Antigen-Induced and Spontaneous Autoimmune Diabetes. Diabetes. 2009;58:1175–84. doi: 10.2337/db08-0616. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 5.Pechhold K, Koczwara K, Zhu X, Harrison VS, Walker G, Lee J, Harlan DM. Blood glucose levels regulate pancreatic beta-cell proliferation during experimentally-induced and spontaneous autoimmune diabetes in mice. PLoS ONE. 2009;4:e4827. doi: 10.1371/journal.pone.0004827. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 6.Tornehave D, Kristensen P, Romer J, Knudsen LB, Heller RS. Expression of the GLP-1 receptor in mouse, rat, and human pancreas. J Histochem Cytochem. 2008;56:841–851. doi: 10.1369/jhc.2008.951319. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 7.Gu G, Wells JM, Dombkowski D, Preffer F, Aronow B, Melton DA. Global expression analysis of gene regulatory pathways during endocrine pancreatic development. Development. 2004;131:165–179. doi: 10.1242/dev.00921. [DOI] [PubMed] [Google Scholar]
- 8.Mellitzer G, Martin M, Sidhoum-Jenny M, Orvain C, Barths J, Seymour PA, Sander M, Gradwohl G. Pancreatic islet progenitor cells in neurogenin 3-yellow fluorescent protein knock-add-on mice. Mol Endocrinol. 2004;18:2765–2776. doi: 10.1210/me.2004-0243. [DOI] [PubMed] [Google Scholar]
- 9.Linden E, Skoglund P, Rundquist I. Accessibility of 7-aminoactinomycin D to lymphocyte nuclei after paraformaldehyde fixation. Cytometry. 1997;27:92–95. doi: 10.1002/(sici)1097-0320(19970101)27:1<92::aid-cyto12>3.0.co;2-n. [DOI] [PubMed] [Google Scholar]
- 10.Sambrook J, Russel DW. In: Molecular Cloning: A Laboratory Manual, Edn. 2. Sambrook J, Russel DW, editors. Cold Spring Harbor Laboratory Press; Cold Spring Harbor, New York: 2001. pp. 7.51–7.62. [Google Scholar]
- 11.Calzone FJ, Britten RJ, Davidson EH. Mapping of gene transcripts by nuclease protection assays and cDNA primer extension. Methods Enzymol. 1987;152:611–632. doi: 10.1016/0076-6879(87)52069-9. [DOI] [PubMed] [Google Scholar]
- 12.Martel RR, Botros IW, Rounseville MP, Hinton JP, Staples RR, Morales DA, Farmer JB, Seligmann BE. Multiplexed screening assay for mRNA combining nuclease protection with luminescent array detection. Assay Drug Dev Technol. 2002;1:61–71. doi: 10.1089/154065802761001310. [DOI] [PubMed] [Google Scholar]
- 13.Wersto RP, Chrest FJ, Leary JF, Morris C, Stetler-Stevenson MA, Gabrielson E. Doublet discrimination in DNA cell-cycle analysis. Cytometry. 2001;46:296–306. doi: 10.1002/cyto.1171. [DOI] [PubMed] [Google Scholar]
- 14.de Jonge HJ, Fehrmann RS, de Bont ES, Hofstra RM, Gerbens F, Kamps WA, de Vries EG, van der Zee AG, te Meerman GJ, ter Elst A. Evidence based selection of housekeeping genes. PLoS ONE. 2007;2:e898. doi: 10.1371/journal.pone.0000898. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 15.Frericks M, Esser C. A toolbox of novel murine house-keeping genes identified by meta-analysis of large scale gene expression profiles. Biochim Biophys Acta. 2008;1779:830–837. doi: 10.1016/j.bbagrm.2008.08.007. [DOI] [PubMed] [Google Scholar]
- 16.Lee PD, Sladek R, Greenwood CM, Hudson TJ. Control genes and variability: absence of ubiquitous reference transcripts in diverse mammalian expression studies. Genome Res. 2002;12:292–297. doi: 10.1101/gr.217802. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 17.Wang J, Webb G, Cao Y, Steiner DF. Contrasting patterns of expression of transcription factors in pancreatic alpha and beta cells. Proc Natl Acad Sci U S A. 2003;100:12660–12665. doi: 10.1073/pnas.1735286100. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 18.Neerman-Arbez M, Cirulli V, Halban PA. Levels of the conversion endoproteases PC1 (PC3) and PC2 distinguish between insulin-producing pancreatic islet beta cells and non-beta cells. Biochem J. 1994;300 ( Pt 1):57–61. doi: 10.1042/bj3000057. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 19.Marcinkiewicz M, Ramla D, Seidah NG, Chretien M. Developmental expression of the prohormone convertases PC1 and PC2 in mouse pancreatic islets. Endocrinology. 1994;135:1651–1660. doi: 10.1210/endo.135.4.7925129. [DOI] [PubMed] [Google Scholar]
- 20.Murtaugh LC. Pancreas and beta-cell development: from the actual to the possible. Development. 2007;134:427–438. doi: 10.1242/dev.02770. [DOI] [PubMed] [Google Scholar]
- 21.Oliver-Krasinski JM, Stoffers DA. On the origin of the beta cell. Genes Dev. 2008;22:1998–2021. doi: 10.1101/gad.1670808. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 22.Nishimura W, Kondo T, Salameh T, El KI, Dodge R, Bonner-Weir S, Sharma A. A switch from MafB to MafA expression accompanies differentiation to pancreatic beta-cells. Dev Biol. 2006;293:526–539. doi: 10.1016/j.ydbio.2006.02.028. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 23.Chimienti F, Devergnas S, Pattou F, Schuit F, Garcia-Cuenca R, Vandewalle B, Kerr-Conte J, Van Lommel L, Grunwald D, Favier A, Seve M. In vivo expression and functional characterization of the zinc transporter ZnT8 in glucose-induced insulin secretion. J Cell Sci. 2006;119:4199–4206. doi: 10.1242/jcs.03164. [DOI] [PubMed] [Google Scholar]
- 24.Gyulkhandanyan AV, Lu H, Lee SC, Bhattacharjee A, Wijesekara N, Fox JE, MacDonald PE, Chimienti F, Dai FF, Wheeler MB. Investigation of transport mechanisms and regulation of intracellular Zn2+ in pancreatic alpha-cells. J Biol Chem. 2008;283:10184–10197. doi: 10.1074/jbc.M707005200. [DOI] [PubMed] [Google Scholar]
- 25.St Onge L, Sosa-Pineda B, Chowdhury K, Mansouri A, Gruss P. Pax6 is required for differentiation of glucagon-producing alpha-cells in mouse pancreas. Nature. 1997;387:406–409. doi: 10.1038/387406a0. [DOI] [PubMed] [Google Scholar]
- 26.Kataoka K. Multiple mechanisms and functions of maf transcription factors in the regulation of tissue-specific genes. J Biochem. 2007;141:775–781. doi: 10.1093/jb/mvm105. [DOI] [PubMed] [Google Scholar]
- 27.Olbrot M, Rud J, Moss LG, Sharma A. Identification of beta-cell-specific insulin gene transcription factor RIPE3b1 as mammalian MafA. Proc Natl Acad Sci U S A. 2002;99:6737–6742. doi: 10.1073/pnas.102168499. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 28.Matsuoka TA, Artner I, Henderson E, Means A, Sander M, Stein R. The MafA transcription factor appears to be responsible for tissue-specific expression of insulin. Proc Natl Acad Sci U S A. 2004;101:2930–2933. doi: 10.1073/pnas.0306233101. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 29.Artner I, Le Lay J, Hang Y, Elghazi L, Schisler JC, Henderson E, Sosa-Pineda B, Stein R. MafB: an activator of the glucagon gene expressed in developing islet alpha- and beta-cells. Diabetes. 2006;55:297–304. doi: 10.2337/diabetes.55.02.06.db05-0946. [DOI] [PubMed] [Google Scholar]
- 30.Parsons JA, Brelje TC, Sorenson RL. Adaptation of islets of Langerhans to pregnancy: increased islet cell proliferation and insulin secretion correlates with the onset of placental lactogen secretion. Endocrinology. 1992;130:1459–1466. doi: 10.1210/endo.130.3.1537300. [DOI] [PubMed] [Google Scholar]
Associated Data
This section collects any data citations, data availability statements, or supplementary materials included in this article.